HEADER IMMUNE SYSTEM 14-APR-05 2BOX TITLE EGF DOMAINS 1,2,5 OF HUMAN EMR2, A 7-TM IMMUNE SYSTEM MOLECULE, IN TITLE 2 COMPLEX WITH STRONTIUM. COMPND MOL_ID: 1; COMPND 2 MOLECULE: EGF-LIKE MODULE CONTAINING MUCIN-LIKE HORMONE RECEPTOR-LIKE COMPND 3 2 PRECURSOR; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: EGF DOMAINS 1,2 AND 5,RESIDUES 25-118,212-260; COMPND 6 SYNONYM: EGF-LIKE MODULE EMR2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: NM554; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: PREP4; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PQE30 KEYWDS CD97, CD55, 7TM, CALCIUM-BINDING, CELL ADHESION, EGF-LIKE DOMAIN, G- KEYWDS 2 PROTEIN COUPLED RECEPTOR, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR R.J.M.ABBOTT,I.SPENDLOVE,P.ROVERSI,P.TERIETE,V.KNOTT,P.A.HANDFORD, AUTHOR 2 J.M.MCDONNELL,S.M.LEA REVDAT 4 13-DEC-23 2BOX 1 REMARK LINK REVDAT 3 25-MAY-11 2BOX 1 VERSN REVDAT 2 24-FEB-09 2BOX 1 VERSN REVDAT 1 18-OCT-06 2BOX 0 JRNL AUTH R.J.M.ABBOTT,I.SPENDLOVE,P.ROVERSI,H.FITZGIBBON,V.KNOTT, JRNL AUTH 2 P.TERIETE,J.M.MCDONNELL,P.A.HANDFORD,S.M.LEA JRNL TITL STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF A NOVEL T CELL JRNL TITL 2 RECEPTOR CO-REGULATORY PROTEIN COMPLEX, CD97-CD55. JRNL REF J.BIOL.CHEM. V. 282 22023 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17449467 JRNL DOI 10.1074/JBC.M702588200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.J.M.ABBOTT,V.KNOTT,P.ROVERSI,S.NEUDECK,P.LUKACIK, REMARK 1 AUTH 2 P.A.HANDFORD,S.M.LEA REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY DIFFRACTION ANALYSIS REMARK 1 TITL 2 OF THREE EGF DOMAINS OF EMR2, A 7TM IMMUNE-SYSTEM MOLECULE REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 60 936 2004 REMARK 1 REFN ISSN 0907-4449 REMARK 1 PMID 15103144 REMARK 1 DOI 10.1107/S0907444904005098 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT 5.6.1 REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.26 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 7342 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.243 REMARK 3 R VALUE (WORKING SET) : 0.240 REMARK 3 FREE R VALUE : 0.284 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 373 REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2426 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2403 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.284 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.00 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 373 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 7342 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1014 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 8 REMARK 3 SOLVENT ATOMS : 94 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : 0.083 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.003 ; 2.000 ; 1055 REMARK 3 BOND ANGLES (DEGREES) : 0.641 ; 3.000 ; 1427 REMARK 3 TORSION ANGLES (DEGREES) : 17.765; 0.000 ; 620 REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : 0.005 ; 2.000 ; 33 REMARK 3 GENERAL PLANES (A) : 0.012 ; 5.000 ; 151 REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : 0.778 ; 20.000; 1056 REMARK 3 NON-BONDED CONTACTS (A) : 0.035 ; 5.000 ; 23 REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : 0 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : BABINET MASKING REMARK 3 KSOL : 0.41 REMARK 3 BSOL : 30.40 REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : TNT CSDX_PROTGEO.DAT REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : TNT BCORREL V1.0 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINED USING BUSTER-TNT VERSION 1.0.4 REMARK 4 REMARK 4 2BOX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-APR-05. REMARK 100 THE DEPOSITION ID IS D_1290023638. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-SEP-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.93300 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8270 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 23.260 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.11000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2BOU (BARIUM COMPLEX OF THE SAME REMARK 200 PROTEIN) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M STRONTIUM CHLORIDE, 12-16% W/V REMARK 280 PEG 8000, 0.1 M NA CACODYLATE BUFFER PH 6.5, PH 6.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 45.55300 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.78750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 45.55300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 30.78750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 1 REMARK 465 SER A 2 REMARK 465 LEU A 50 REMARK 465 SER A 51 REMARK 465 LYS A 52 REMARK 465 VAL A 53 REMARK 465 ARG A 124 REMARK 465 PRO A 125 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 17 -158.65 -162.70 REMARK 500 SER A 67 -151.62 -157.15 REMARK 500 SER A 108 -6.43 -58.42 REMARK 500 SER A 118 -156.38 -159.65 REMARK 500 ASN A 136 34.61 76.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 SR A1145 SR REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 43 OD2 REMARK 620 2 ASP A 43 OD1 46.5 REMARK 620 3 ILE A 44 O 77.3 92.0 REMARK 620 4 GLU A 46 OE1 138.8 144.7 64.9 REMARK 620 5 ASN A 63 OD1 78.9 123.6 87.6 83.7 REMARK 620 6 THR A 64 O 75.5 72.5 152.4 138.7 82.7 REMARK 620 7 SER A 67 O 140.0 130.6 135.1 70.9 80.0 68.4 REMARK 620 8 CL A1146 CL 114.6 74.7 79.2 74.9 158.1 116.6 96.9 REMARK 620 N 1 2 3 4 5 6 7 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 SR A1144 SR REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 95 OD1 REMARK 620 2 ASP A 95 OD2 45.6 REMARK 620 3 VAL A 96 O 88.6 76.4 REMARK 620 4 GLU A 98 OE2 141.9 139.3 65.7 REMARK 620 5 ASN A 114 OD1 129.5 84.5 86.2 78.7 REMARK 620 6 THR A 115 O 80.9 79.1 153.7 133.6 82.1 REMARK 620 7 SER A 118 O 125.9 136.0 143.0 77.7 81.2 57.8 REMARK 620 8 HOH A2076 O 75.8 117.1 82.7 73.4 152.2 117.4 92.5 REMARK 620 N 1 2 3 4 5 6 7 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SR A 1144 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SR A 1145 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1146 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CAC A 1147 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2BO2 RELATED DB: PDB REMARK 900 EGF DOMAINS 1,2,5 OF HUMAN EMR2, A 7-TM IMMUNE SYSTEM MOLECULE, IN REMARK 900 COMPLEX WITH CALCIUM. REMARK 900 RELATED ID: 2BOU RELATED DB: PDB REMARK 900 EGF DOMAINS 1,2,5 OF HUMAN EMR2, A 7-TM IMMUNE SYSTEM MOLECULE, IN REMARK 900 COMPLEX WITH BARIUM. REMARK 999 REMARK 999 SEQUENCE REMARK 999 THIS PDB DESCIBES THE ALTERNATIVELY SPLICED ISOFORM C OF REMARK 999 THE GENE ID 30817 LOCUS TAG HGNC3337 OMIM 606100 DBREF 2BOX A 1 94 UNP Q9UHX3 EMR2_HUMAN 25 118 DBREF 2BOX A 95 143 UNP Q9UHX3 EMR2_HUMAN 212 260 SEQRES 1 A 143 ASP SER ARG GLY CYS ALA ARG TRP CYS PRO GLN ASP SER SEQRES 2 A 143 SER CYS VAL ASN ALA THR ALA CYS ARG CYS ASN PRO GLY SEQRES 3 A 143 PHE SER SER PHE SER GLU ILE ILE THR THR PRO MET GLU SEQRES 4 A 143 THR CYS ASP ASP ILE ASN GLU CYS ALA THR LEU SER LYS SEQRES 5 A 143 VAL SER CYS GLY LYS PHE SER ASP CYS TRP ASN THR GLU SEQRES 6 A 143 GLY SER TYR ASP CYS VAL CYS SER PRO GLY TYR GLU PRO SEQRES 7 A 143 VAL SER GLY ALA LYS THR PHE LYS ASN GLU SER GLU ASN SEQRES 8 A 143 THR CYS GLN ASP VAL ASP GLU CYS SER SER GLY GLN HIS SEQRES 9 A 143 GLN CYS ASP SER SER THR VAL CYS PHE ASN THR VAL GLY SEQRES 10 A 143 SER TYR SER CYS ARG CYS ARG PRO GLY TRP LYS PRO ARG SEQRES 11 A 143 HIS GLY ILE PRO ASN ASN GLN LYS ASP THR VAL CYS GLU HET SR A1144 1 HET SR A1145 1 HET CL A1146 1 HET CAC A1147 5 HETNAM SR STRONTIUM ION HETNAM CL CHLORIDE ION HETNAM CAC CACODYLATE ION HETSYN CAC DIMETHYLARSINATE FORMUL 2 SR 2(SR 2+) FORMUL 4 CL CL 1- FORMUL 5 CAC C2 H6 AS O2 1- FORMUL 6 HOH *94(H2 O) HELIX 1 1 ASN A 45 THR A 49 5 5 HELIX 2 2 ASN A 87 ASN A 91 5 5 SHEET 1 AA 2 SER A 13 CYS A 15 0 SHEET 2 AA 2 CYS A 21 CYS A 23 -1 O ARG A 22 N SER A 14 SHEET 1 AB 2 PHE A 27 SER A 28 0 SHEET 2 AB 2 ASP A 42 ASP A 43 -1 O ASP A 42 N SER A 28 SHEET 1 AC 2 SER A 59 THR A 64 0 SHEET 2 AC 2 SER A 67 CYS A 72 -1 O SER A 67 N THR A 64 SHEET 1 AD 2 TYR A 76 PRO A 78 0 SHEET 2 AD 2 CYS A 93 ASP A 95 -1 O GLN A 94 N GLU A 77 SHEET 1 AE 2 VAL A 111 THR A 115 0 SHEET 2 AE 2 SER A 118 ARG A 122 -1 O SER A 118 N THR A 115 SSBOND 1 CYS A 5 CYS A 15 1555 1555 2.03 SSBOND 2 CYS A 9 CYS A 21 1555 1555 2.03 SSBOND 3 CYS A 23 CYS A 41 1555 1555 2.03 SSBOND 4 CYS A 47 CYS A 61 1555 1555 2.03 SSBOND 5 CYS A 55 CYS A 70 1555 1555 2.03 SSBOND 6 CYS A 72 CYS A 93 1555 1555 2.03 SSBOND 7 CYS A 99 CYS A 112 1555 1555 2.03 SSBOND 8 CYS A 106 CYS A 121 1555 1555 2.03 SSBOND 9 CYS A 123 CYS A 142 1555 1555 2.03 LINK OD2 ASP A 43 SR SR A1145 1555 1555 2.87 LINK OD1 ASP A 43 SR SR A1145 1555 1555 2.66 LINK O ILE A 44 SR SR A1145 1555 1555 2.50 LINK OE1 GLU A 46 SR SR A1145 1555 1555 2.63 LINK OD1 ASN A 63 SR SR A1145 1555 1555 2.50 LINK O THR A 64 SR SR A1145 1555 1555 2.58 LINK O SER A 67 SR SR A1145 1555 1555 2.52 LINK OD1 ASP A 95 SR SR A1144 1555 1555 2.64 LINK OD2 ASP A 95 SR SR A1144 1555 1555 2.96 LINK O VAL A 96 SR SR A1144 1555 1555 2.51 LINK OE2 GLU A 98 SR SR A1144 1555 1555 2.40 LINK OD1 ASN A 114 SR SR A1144 1555 1555 2.72 LINK O THR A 115 SR SR A1144 1555 1555 2.65 LINK O SER A 118 SR SR A1144 1555 1555 2.60 LINK SR SR A1144 O HOH A2076 1555 1555 2.74 LINK SR SR A1145 CL CL A1146 1555 1555 2.59 SITE 1 AC1 7 ASP A 95 VAL A 96 GLU A 98 ASN A 114 SITE 2 AC1 7 THR A 115 SER A 118 HOH A2076 SITE 1 AC2 7 ASP A 43 ILE A 44 GLU A 46 ASN A 63 SITE 2 AC2 7 THR A 64 SER A 67 CL A1146 SITE 1 AC3 7 GLY A 26 ASP A 43 ILE A 44 GLU A 46 SITE 2 AC3 7 GLY A 66 SER A 67 SR A1145 SITE 1 AC4 3 GLY A 56 SER A 59 ASP A 60 CRYST1 91.106 61.575 35.495 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010976 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016240 0.000000 0.00000 SCALE3 0.000000 0.000000 0.028173 0.00000